Disruptive technology remains vital to the future of healthcare. "If you think about what's happening in AI and machine-learning drug discovery: those are exciting places to be," says Andrew Callaway, RBC's Global Head, Healthcare Investment Banking. Learn how wearables and digital therapeutics are emerging as important licensing opportunities today, but could be focal points for M&A tomorrow. Hear from RBC's experts.
Many Blue Cross Blue Shield plans aren’t paying taxes; tracking an FDA meeting on Covid vaccines in young children
Reviewed by Knowledge World
on
June 15, 2022
Rating: 5
No comments